Literature DB >> 403199

Evaluation of a simple device for bacteriological sampling of respirator-generated aerosols.

K J Ryan, S F Mihalyi.   

Abstract

The Aerotest sampler (Olympic Medical Corp., Seattle, Wash.) is designed to detect bacterial contamination of respirator-generated aerosols in a simple one-step process. The sampler was evaluated by controlled contamination of Bennett AP-5, PR-2, and MA-1 respirators with Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter. Bacteria present as viable 1.4 to 3.5-mum particles in each of 77 aerosols were quantitated by using the Andersen viable-particle sampler, and the results were compared with those of colonies obtained from 10-s or 15-cycle Aerotest samples. All aerosols containing counts greater than expected in hospital air were detected by the Aerotest method. Thirteen of 14 aerosols containing less than 20 bacteria/0.028 m3 showed fewer than 5 colonies, whereas all aerosols containing greater than 1,000 bacteria/0.028 m3 showed at least 40 colonies. Aerosols with intermediate counts fell in between. Under the conditions described here, the Aerotest sampler was able to discriminate between the low levels of bacteria commonly found in hospital air and the bacterial contamination associated with nosocomial pneumonia. The Aerotest sampler provides a practical method for surveillance sampling of respirator nebulizers.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 403199      PMCID: PMC274560          DOI: 10.1128/jcm.5.2.178-183.1977

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION.

Authors:  J A REINARZ; A K PIERCE; B B MAYS; J P SANFORD
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

2.  Microbiological contamination of hospital air. I. Quantitative studies.

Authors:  V W GREENE; D VESLEY; R G BOND; G S MICHAELSEN
Journal:  Appl Microbiol       Date:  1962-11

3.  THE USE OF ETHYLENE OXIDE FOR STERILIZATION OF MECHANICAL VENTILATORS.

Authors:  C BISHOP; D S ROBERTSON; S R WILLIAMS
Journal:  Br J Anaesth       Date:  1964-01       Impact factor: 9.166

Review 4.  Bacterial contamination of aerosols.

Authors:  A K Pierce; J P Sanford
Journal:  Arch Intern Med       Date:  1973-01

5.  Pseudomonas aeruginosa cross-infection due to contaminated respiratory apparatus.

Authors:  I Phillips; G Spencer
Journal:  Lancet       Date:  1965-12-25       Impact factor: 79.321

6.  Disinfection of lung ventilators by alcohol aerosol.

Authors:  G Spencer; M Ridley; S Eykyn; J Achong
Journal:  Lancet       Date:  1968-09-21       Impact factor: 79.321

7.  Disinfection of ventilators by ultrasonic nebulisation.

Authors:  P A Judd; P J Tomlin; J L Whitby; T C Inglis; J S Robinson
Journal:  Lancet       Date:  1968-11-09       Impact factor: 79.321

8.  Long-term evaluation of decontamination of inhalation-therapy equipment and the occurrence of necrotizing pneumonia.

Authors:  A K Pierce; J P Sanford; G D Thomas; J S Leonard
Journal:  N Engl J Med       Date:  1970-03-05       Impact factor: 91.245

9.  A practical method for monitoring bacterial contamination of inhalation therapy machines.

Authors:  M M Nazemi; D M Musher; R R Martin
Journal:  Am Rev Respir Dis       Date:  1972-12

10.  "In use" study of buffered glutaraldehyde for cold sterilization of anesthesia equipment.

Authors:  D H Haselhuhn; F W Brason; P M Borick
Journal:  Anesth Analg       Date:  1967 Jul-Aug       Impact factor: 5.108

View more
  2 in total

1.  Limulus amoebocyte lysate and direct sampling methods for surveillance of operating nebulizers.

Authors:  D J Reinhardt; W Nabors; C Kennedy; B Malecka-Griggs
Journal:  Appl Environ Microbiol       Date:  1981-11       Impact factor: 4.792

2.  Selective nonroutine microbial surveillance of in-use hospital nebulizers by aerosol entrapment and direct sampling analyses of solutions in reservoirs.

Authors:  D J Reinhardt; C Kennedy; B Malecka-Griggs
Journal:  J Clin Microbiol       Date:  1980-08       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.